Author: OurCrowd

[Innoviz in PR Newswire] Innoviz Technologies to host a 3-day Global Distributor Summit and expand LiDAR sales for non-automotive markets

TEL AVIV, Israel, Nov. 7, 2022 /PRNewswire/ — Innoviz Technologies (NASDAQ: INVZ) (the “Company” or “Innoviz”), a technology leader of high-performance, solid-state LiDAR sensors and perception software, announced it significantly expanded its production capability and will host a Global Distributor Summit for its worldwide distributors that help customers purchase and integrate InnovizOne LiDAR. The summit will be at the Company’s new headquarters in Israel from November 14-17, 2022, and support InnovizOne LiDAR sales for non-automotive markets beginning in Q4 2022 and ramping up into 2023. Read more...

Read More

[Insightec in PR Newswire] Insightec’s focused ultrasound for essential tremor study results demonstrated sustained and significant tremor improvement maintained out to 5 years

HAIFA, Israel and MIAMI, Nov. 7, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced the publication of the largest prospective, long-term follow-up study of unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor to date. Read...

Read More

[OncoHost in PR Newswire] OncoHost to present proteomics-based biomarker model for clinical benefit to immunotherapy in NSCLC patients at SITC 2022

BINYAMINA, Israel , Nov. 7, 2022 /PRNewswire/ — OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, has developed a novel predictive model for clinical benefit of immune checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients. The model is based on proteomic profiling of pre-treatment blood samples, combined with machine learning analysis that accurately predicts clinical benefit probability at twelve months, outperforming the predictive capabilities of the existing PD-L1 biomarker. The study was conducted using OncoHost’s first-of-its-kind PROphet® platform, and will be presented as a poster at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting. Read...

Read More

[yulife in PR Newswire] New total economic impact study: Insuring with YuLife generates 181% ROI compared to traditional insurance providers

LONDON, Nov. 7, 2022 /PRNewswire/ — YuLife, the tech-driven financial services brand on a mission to inspire life, today released the results of a commissioned Total Economic Impact™ (TEI) study conducted by Forrester Consulting which identified that the return on investment (ROI) generated by insuring with YuLife is 181%, when switching to YuLife from traditional insurance providers. Read...

Read More